Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CinDome Pharma
AddedFeb 15, 2024
UpdatedJun 18, 2026
CinDome Pharma

CinDome Pharma

CinDome Pharma: Ohio-based medical organization providing treatment for chronic gastroparesis.

HQ
Cincinnati, OH, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

CinDome Pharma, founded in Cincinnati, Ohio, focuses on providing treatment for chronic gastroparesis, a debilitating gastrointestinal disorder. The company's mission is to improve the quality of life for millions affected by this condition through innovative medical solutions. CinDome Pharma is working on developing safer and more effective treatments than the currently available options, which include metoclopramide and domperidone, both of which have significant side effects and limitations.

Notable figures associated with CinDome Pharma include Dr. Brad Kuo from Massachusetts General Hospital. The company has made significant strides in addressing the unmet medical needs in gastroparesis treatment, aiming to offer safer alternatives to existing medications that carry severe risks like tardive dyskinesia and cardiovascular issues. CinDome Pharma's impact lies in its potential to revolutionize gastroparesis treatment, providing hope and improved health outcomes for patients worldwide.

CinDome Pharma - Similar Companies

CinRx Pharma logo

CinRx Pharma

cinrx.com

Chorda Pharma logo

Chorda Pharma

chordapharma.com

Neurogastrx logo

Neurogastrx

neurogastrx.com

cystetic Medicines logo

cystetic Medicines

PleoPharma logo

PleoPharma

pleopharma.com

Patients' & Consumers' Pharma logo

Patients' & Consumers' Pharma

Xdynia logo

Xdynia

Endosphere logo

Endosphere

Cortria logo

Cortria

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

Evoke Pharma logo

Evoke Pharma

evokepharma.com

Camino Pharma logo

Camino Pharma

caminopharma.com

Synchroneuron logo

Synchroneuron

Amulet Pharmaceuticals logo

Amulet Pharmaceuticals

Cumberland Pharmaceuticals logo

Cumberland Pharmaceuticals

CinDome Pharma - Quick Facts

Who are CinDome Pharma's competitors?

Companies similar to CinDome Pharma include CinRx Pharma, Chorda Pharma, Neurogastrx and cystetic Medicines.

When was CinDome Pharma founded?

CinDome Pharma was founded in 2019.

Where is CinDome Pharma's headquarters located?

CinDome Pharma's headquarters is located in Cincinnati, OH, US.

When was CinDome Pharma's last funding round?

CinDome Pharma's most recent funding round was for $19M (USD) in April 2023.

How much has CinDome Pharma raised to-date?

As of Apr 27, 2023, CinDome Pharma has raised a total of $19M (USD).

How many employees does CinDome Pharma have?

CinDome Pharma has 30 employees as of Feb 4, 2024.

CinDome Pharma - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Treatment
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified